ID   S5A1_RAT                Reviewed;         259 AA.
AC   P24008; A0JPJ6;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   29-MAY-2024, entry version 166.
DE   RecName: Full=3-oxo-5-alpha-steroid 4-dehydrogenase 1 {ECO:0000305};
DE            EC=1.3.1.22;
DE   AltName: Full=SR type 1;
DE   AltName: Full=Steroid 5-alpha-reductase 1;
DE            Short=S5AR 1;
GN   Name=Srd5a1 {ECO:0000312|RGD:3757};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
RX   PubMed=2476440; DOI=10.1016/s0021-9258(18)71614-1;
RA   Andersson S., Bishop R.W., Russell D.W.;
RT   "Expression cloning and regulation of steroid 5 alpha-reductase, an enzyme
RT   essential for male sexual differentiation.";
RL   J. Biol. Chem. 264:16249-16255(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
RC   TISSUE=Liver;
RX   PubMed=8597599; DOI=10.1016/0167-4781(95)00198-0;
RA   Lopez-Solache I., Luu-The V., Seralini G.E., Labrie F.;
RT   "Heterogeneity of rat type I 5 alpha-reductase cDNA: cloning, expression
RT   and regulation by pituitary implants and dihydrotestosterone.";
RL   Biochim. Biophys. Acta 1305:139-144(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SHORT).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   CATALYTIC ACTIVITY, FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=2339109; DOI=10.1073/pnas.87.10.3640;
RA   Andersson S., Russell D.W.;
RT   "Structural and biochemical properties of cloned and expressed human and
RT   rat steroid 5 alpha-reductases.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:3640-3644(1990).
CC   -!- FUNCTION: Converts testosterone into 5-alpha-dihydrotestosterone and
CC       progesterone or corticosterone into their corresponding 5-alpha-3-
CC       oxosteroids. It plays a central role in sexual differentiation and
CC       androgen physiology. {ECO:0000269|PubMed:2339109}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 3-oxo-5alpha-steroid + NADP(+) = a 3-oxo-Delta(4)-steroid +
CC         H(+) + NADPH; Xref=Rhea:RHEA:54384, ChEBI:CHEBI:13601,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:47909, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.3.1.22;
CC         Evidence={ECO:0000305|PubMed:2476440};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:54386;
CC         Evidence={ECO:0000305|PubMed:2476440};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=5alpha-pregnane-3,20-dione + NADP(+) = H(+) + NADPH +
CC         progesterone; Xref=Rhea:RHEA:21952, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17026, ChEBI:CHEBI:28952, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.3.1.22;
CC         Evidence={ECO:0000269|PubMed:2476440};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:21954;
CC         Evidence={ECO:0000305|PubMed:2476440};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-hydroxy-5alpha-androstan-3-one + NADP(+) = H(+) + NADPH
CC         + testosterone; Xref=Rhea:RHEA:50820, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16330, ChEBI:CHEBI:17347, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.3.1.22;
CC         Evidence={ECO:0000269|PubMed:2476440};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:50822;
CC         Evidence={ECO:0000305|PubMed:2476440};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=androst-4-ene-3,17-dione + H(+) + NADPH = 5alpha-androstan-
CC         3,17-dione + NADP(+); Xref=Rhea:RHEA:50816, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15994, ChEBI:CHEBI:16422, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; Evidence={ECO:0000269|PubMed:2476440};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50817;
CC         Evidence={ECO:0000305|PubMed:2476440};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.5 uM for testosterone {ECO:0000269|PubMed:2339109};
CC         KM=2.8 uM for androstenedione {ECO:0000269|PubMed:2339109};
CC         KM=0.5 uM for progesterone {ECO:0000269|PubMed:2339109};
CC         Vmax=2.5 nmol/min/mg enzyme toward testosterone
CC         {ECO:0000269|PubMed:2339109};
CC         Vmax=2.2 nmol/min/mg enzyme toward androstenedione
CC         {ECO:0000269|PubMed:2339109};
CC         Vmax=1.8 nmol/min/mg enzyme toward progesterone
CC         {ECO:0000269|PubMed:2339109};
CC       pH dependence:
CC         Optimally active at alkaline pHs.;
CC   -!- SUBCELLULAR LOCATION: Microsome membrane; Multi-pass membrane protein.
CC       Endoplasmic reticulum membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P24008-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P24008-2; Sequence=VSP_018884;
CC   -!- TISSUE SPECIFICITY: Liver and prostate (at a low level).
CC   -!- DEVELOPMENTAL STAGE: After the establishment of chromosomal sex at
CC       fertilization.
CC   -!- INDUCTION: Its expression is regulated by androgens such as
CC       testosterone.
CC   -!- SIMILARITY: Belongs to the steroid 5-alpha reductase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J05035; AAA42102.1; -; mRNA.
DR   EMBL; S81448; AAB36218.1; -; mRNA.
DR   EMBL; BC127454; AAI27455.1; -; mRNA.
DR   PIR; S65744; S65744.
DR   RefSeq; NP_058766.2; NM_017070.3. [P24008-2]
DR   AlphaFoldDB; P24008; -.
DR   SMR; P24008; -.
DR   STRING; 10116.ENSRNOP00000023659; -.
DR   BindingDB; P24008; -.
DR   ChEMBL; CHEMBL3422; -.
DR   DrugCentral; P24008; -.
DR   SwissLipids; SLP:000001641; -.
DR   PhosphoSitePlus; P24008; -.
DR   PaxDb; 10116-ENSRNOP00000023659; -.
DR   Ensembl; ENSRNOT00000023659.7; ENSRNOP00000023659.6; ENSRNOG00000017601.8. [P24008-2]
DR   GeneID; 24950; -.
DR   KEGG; rno:24950; -.
DR   UCSC; RGD:3757; rat. [P24008-1]
DR   AGR; RGD:3757; -.
DR   CTD; 6715; -.
DR   RGD; 3757; Srd5a1.
DR   VEuPathDB; HostDB:ENSRNOG00000017601; -.
DR   eggNOG; KOG1638; Eukaryota.
DR   GeneTree; ENSGT00950000182886; -.
DR   InParanoid; P24008; -.
DR   OMA; PHYALEW; -.
DR   OrthoDB; 152402at2759; -.
DR   PhylomeDB; P24008; -.
DR   BRENDA; 1.3.1.22; 5301.
DR   Reactome; R-RNO-193048; Androgen biosynthesis.
DR   SABIO-RK; P24008; -.
DR   PRO; PR:P24008; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000017601; Expressed in liver and 20 other cell types or tissues.
DR   GO; GO:0070852; C:cell body fiber; IDA:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0003865; F:3-oxo-5-alpha-steroid 4-dehydrogenase activity; IDA:RGD.
DR   GO; GO:0047751; F:3-oxo-5alpha-steroid 4-dehydrogenase (NADP+) activity; IEA:UniProtKB-EC.
DR   GO; GO:0033218; F:amide binding; IDA:RGD.
DR   GO; GO:0070402; F:NADPH binding; IDA:RGD.
DR   GO; GO:0006702; P:androgen biosynthetic process; IDA:RGD.
DR   GO; GO:0006710; P:androgen catabolic process; IDA:RGD.
DR   GO; GO:0008209; P:androgen metabolic process; IDA:RGD.
DR   GO; GO:0060348; P:bone development; IEP:RGD.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0071320; P:cellular response to cAMP; IEP:RGD.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEP:RGD.
DR   GO; GO:0071872; P:cellular response to epinephrine stimulus; IEP:RGD.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEP:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEP:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0009267; P:cellular response to starvation; IEP:RGD.
DR   GO; GO:0071394; P:cellular response to testosterone stimulus; IEP:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0016101; P:diterpenoid metabolic process; IEP:RGD.
DR   GO; GO:0030540; P:female genitalia development; IEP:RGD.
DR   GO; GO:0021766; P:hippocampus development; IEP:RGD.
DR   GO; GO:0021854; P:hypothalamus development; IEP:RGD.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0030539; P:male genitalia development; IEP:RGD.
DR   GO; GO:0008584; P:male gonad development; IEP:RGD.
DR   GO; GO:0046661; P:male sex differentiation; TAS:RGD.
DR   GO; GO:0021983; P:pituitary gland development; IEP:RGD.
DR   GO; GO:0042448; P:progesterone metabolic process; IDA:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0043627; P:response to estrogen; IEP:RGD.
DR   GO; GO:0032354; P:response to follicle-stimulating hormone; IEP:RGD.
DR   GO; GO:0060992; P:response to fungicide; IEP:RGD.
DR   GO; GO:0060416; P:response to growth hormone; IEP:RGD.
DR   GO; GO:0014850; P:response to muscle activity; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0033574; P:response to testosterone; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IMP:RGD.
DR   GO; GO:0042428; P:serotonin metabolic process; IEP:RGD.
DR   GO; GO:0021510; P:spinal cord development; IEP:RGD.
DR   GO; GO:0006694; P:steroid biosynthetic process; IDA:RGD.
DR   GO; GO:0021794; P:thalamus development; IEP:RGD.
DR   GO; GO:0001655; P:urogenital system development; IEP:RGD.
DR   Gene3D; 1.20.120.1630; -; 1.
DR   InterPro; IPR016636; 3-oxo-5-alpha-steroid_4-DH.
DR   InterPro; IPR001104; 3-oxo-5_a-steroid_4-DH_C.
DR   InterPro; IPR039357; SRD5A/TECR.
DR   PANTHER; PTHR10556; 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE; 1.
DR   PANTHER; PTHR10556:SF57; 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE 1; 1.
DR   Pfam; PF02544; Steroid_dh; 1.
DR   PIRSF; PIRSF015596; 5_alpha-SR2; 1.
DR   PROSITE; PS50244; S5A_REDUCTASE; 1.
PE   1: Evidence at protein level;
KW   Alternative initiation; Differentiation; Endoplasmic reticulum;
KW   Lipid metabolism; Membrane; Microsome; NADP; Oxidoreductase;
KW   Reference proteome; Sexual differentiation; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..259
FT                   /note="3-oxo-5-alpha-steroid 4-dehydrogenase 1"
FT                   /id="PRO_0000031565"
FT   TRANSMEM        10..30
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        86..106
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        111..131
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        146..166
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        206..226
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..4
FT                   /note="Missing (in isoform Short)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:2476440"
FT                   /id="VSP_018884"
SQ   SEQUENCE   259 AA;  29780 MW;  FE6705AC1D7CAE11 CRC64;
     MVPLMELDEL CLLDMLVYLE GFMAFVSIVG LRSVGSPYGR YSPQWPGIRV PARPAWFIQE
     LPSMAWPLYE YIRPAAARLG NLPNRVLLAM FLIHYVQRTL VFPVLIRGGK PTLLVTFVLA
     FLFCTFNGYV QSRYLSQFAV YAEDWVTHPC FLTGFALWLV GMVINIHSDH ILRNLRKPGE
     TGYKIPRGGL FEYVSAANYF GELVEWCGFA LASWSLQGVV FALFTLSTLL TRAKQHHQWY
     HEKFEDYPKS RKILIPFVL
//
